Phase I/II Randomized, Open-label Trial to Evaluate the PK, Safety, and Outcomes of Treatment Including High Dose Rifampicin +/- Levofloxacin vs Standard Treatment for Pediatric Tuberculous Meningitis (TBM)
Latest Information Update: 03 Oct 2021
At a glance
- Drugs Levofloxacin (Primary) ; Rifampicin (Primary) ; Ethambutol; Isoniazid; Pyrazinamide; Steroids
- Indications Tubercular meningitis
- Focus Adverse reactions; Pharmacokinetics
- Acronyms TBM-KIDS
- 22 Jan 2021 Status changed from active, no longer recruiting to completed.
- 12 Nov 2020 Planned End Date changed from 1 Nov 2020 to 1 Jun 2021.
- 12 Nov 2020 Planned primary completion date changed from 1 Nov 2020 to 1 Jun 2021.